Scribe Therapeutics Inc. Common Stock (SCTX) — Financial Flexibility Index
Scribe Therapeutics Inc. Common Stock (SCTX) has a Financial Flexibility Index of -0.02x as of June 2026. Free cash flow of $-5.33 Million (operating CF $-5.34 Million minus capex $10.00K) represents 0% of total liabilities ($222.77 Million). Check Scribe Therapeutics Inc. Common Stock (SCTX) asset resilience to evaluate the company's liquid asset resilience ratio.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Scribe Therapeutics Inc. Common Stock Financial Flexibility Index (2024–2025)
Historical Financial Flexibility Index trend for Scribe Therapeutics Inc. Common Stock across 2 annual periods. Explore Scribe Therapeutics Inc. Common Stock debt service capacity to assess how comfortably operating cash covers total debt obligations.
Annual Financial Flexibility Index for Scribe Therapeutics Inc. Common Stock (2024–2025)
Year-by-year free cash flow to debt coverage for Scribe Therapeutics Inc. Common Stock. For the full cash flow conversion analysis, see cash efficiency ratio of Scribe Therapeutics Inc. Common Stock.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.20x | $-43.94 Million | $-45.21 Million | $221.64 Million | ▼ -14.7% |
| 2024 | -0.17x | $-43.89 Million | $-45.23 Million | $253.83 Million | — |